您還需要查看 Eliquis 的利潤貢獻

GREED WATCH: Bristol Myers Squibb Brought In More Than $45 Billion In 2023

https://www.protectourcare.org/greed-watch-bristol-myers-squibb-brought-in-more-than-45-billion-in-2023/

2019年FDA已批準Eliquis仿製藥。 BMY使用各種策略將其專利延長至2026年。為什麽？ 藥品貢獻了其2/3的利潤。 Eliquis是Medicare處方中的NO.1藥物，受益人數最多的會員 (3.5 million)。雖然Medicare花費最多的不是Eliquis，而是兩種癌症藥物，每種藥物隻惠及不到3萬名會員。

Eiquis is at about $600 a month.  Many Medicare Advantage plans cover it with only $5 co-pay  but pay the full cost of the drug. 

2024 Medicar Plan D allowance is 5030.  Once over that you enter the donut hole (coverage gap)

At $600 a month, a patient even ONLY needs Eliquis (hardly likely),  would go into donut hole by August. 

8x600 = 4800. 

一旦進入 Donut Hole，患者將承擔25%的藥品費用加上配藥費（由配藥的藥房收取）。

Basically BMY is a 吸血者.  It is about time to do something to stop the sleazy tactics big pharma used, i.e. using loophole to extend patent.

所有跟帖： 

• 這個聽上去就像是FDA的問題呀 -自了漢- ♂ (45 bytes) () 04/30/2024 postreply 08:34:18

• No. Patent can be legally extended thru many ways. -goingplaces- ♀ (102 bytes) () 04/30/2024 postreply 10:48:25